Michael joined Novo Ventures in November 2020. From 2006-2020, Michael was employed at Genmab in various positions with increasing responsibility; starting in Project Management taking daratumumab / DARZALEX® into the clinic. Between 2010-2018 he led Clinical Development and was part of the senior leadership team that repositioned and rebuilt the company into a global cancer...
Is this you? Claim this profile →
No public contact links on file.
Speaking history
Sourcing speakers for your event?
Browse the speaker directory →